Investors with a medium-term perspective can buy the stock of Camlin Fine Sciences (₹140.4), a small-cap speciality chemicals stock. Since recording a 52-week low at ₹33 in March 2020, the stock has been in an intermediate-term uptrend, forming higher peaks and higher troughs. Medium- and short-term trend are up for the stock. A significant support at ₹100 had cushioned it in late January this year. Subsequently, the stock continued to trend upwards, resuming the intermediate-term uptrend. In late February, it surpassed the 21- and 50-day moving averages and extended the rally, backed with good volume. However, the stock had met with a key resistance at ₹160 in early March and was on a minor correction that lasted slightly over a week.
Last week, the stock took medium-term support in the band between ₹128 and ₹132 and bounced. On Friday, the stock gained 5 per cent with good volume, forming a bullish engulfing candlestick pattern on the daily chart, indicating bullish reversal and end of corrective decline. The daily relative strength index is likely to re-enter the bullish zone from the neutral region and the weekly RSI likely to continue to feature in the bullish zone.
Overall, the short to medium-term outlook is bullish for the stock of Camlin Fine Sciences. It has potential to trend upwards and reach the price targets of ₹155 and ₹161 with a minor pause at ₹155 over the medium term. Traders can buy the stock with a stop-loss at ₹130.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.